Literature DB >> 16982831

Neutrophil elastase, an innate immunity effector molecule, represses flagellin transcription in Pseudomonas aeruginosa.

Avinash Sonawane1, Jeevan Jyot, Russell During, Reuben Ramphal.   

Abstract

Recognition of pathogen-associated molecular patterns (PAMPs) by pattern recognition receptors triggers an innate immune response to colonizing or invading bacteria. Conversely, many bacteria have evolved mechanisms to dampen this response by downregulating the synthesis of such PAMPs. We have previously demonstrated that Pseudomonas aeruginosa growing in mucopurulent human respiratory mucus from cystic fibrosis patients represses the expression of its flagellin, a potent stimulant of the innate immune response. Here we demonstrate that this phenomenon occurs in response to the presence of neutrophil elastase in such mucus. Nonpurulent mucus from animals had no such repressive effect. Furthermore, lysed neutrophils from human blood reproduced the flagellin-repressive effect ex mucus and, significantly, had no effect on the viability of this organism. Neutrophil elastase, a component of the innate host defense system, has been described to be bactericidal for gram-negative bacteria and to degrade bacterial virulence factors. Thus, the resistance of P. aeruginosa to the bactericidal effect of neutrophil elastase, as well as this organism's ability to sense this enzyme's presence and downregulate the synthesis of a PAMP, may be the key factors in allowing P. aeruginosa to colonize the lungs. These findings demonstrate the dynamic nature of this bacterium's response to host defenses that ensures its success as a colonizer and also highlights the dual nature of defense molecules that confer advantages and disadvantages to both hosts and pathogens.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982831      PMCID: PMC1698043          DOI: 10.1128/IAI.00922-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Recognition of host immune activation by Pseudomonas aeruginosa.

Authors:  Licheng Wu; Oscar Estrada; Olga Zaborina; Manjeet Bains; Le Shen; Jonathan E Kohler; Nachiket Patel; Mark W Musch; Eugene B Chang; Yang-Xin Fu; Michael A Jacobs; Michael I Nishimura; Robert E W Hancock; Jerrold R Turner; John C Alverdy
Journal:  Science       Date:  2005-07-29       Impact factor: 47.728

2.  Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.

Authors:  Eric E Smith; Danielle G Buckley; Zaining Wu; Channakhone Saenphimmachak; Lucas R Hoffman; David A D'Argenio; Samuel I Miller; Bonnie W Ramsey; David P Speert; Samuel M Moskowitz; Jane L Burns; Rajinder Kaul; Maynard V Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-10       Impact factor: 11.205

3.  Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha 1-protease inhibitor reactive site.

Authors:  K Nakajima; J C Powers; B M Ashe; M Zimmerman
Journal:  J Biol Chem       Date:  1979-05-25       Impact factor: 5.157

4.  Aerosol alpha 1-antitrypsin treatment for cystic fibrosis.

Authors:  N G McElvaney; R C Hubbard; P Birrer; M S Chernick; D B Caplan; M M Frank; R G Crystal
Journal:  Lancet       Date:  1991-02-16       Impact factor: 79.321

5.  Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection.

Authors:  M Feldman; R Bryan; S Rajan; L Scheffler; S Brunnert; H Tang; A Prince
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

6.  Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology.

Authors:  Kelli L Palmer; Lauren M Mashburn; Pradeep K Singh; Marvin Whiteley
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

7.  Transcriptome analysis of the response of Pseudomonas aeruginosa to hydrogen peroxide.

Authors:  Marco Palma; Darrow DeLuca; Stefan Worgall; Luis E N Quadri
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

8.  Compartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia.

Authors:  A Boutten; M S Dehoux; N Seta; J Ostinelli; P Venembre; B Crestani; M C Dombret; G Durand; M Aubier
Journal:  Am J Respir Crit Care Med       Date:  1996-01       Impact factor: 21.405

9.  Three human elastase-like genes coordinately expressed in the myelomonocyte lineage are organized as a single genetic locus on 19pter.

Authors:  M Zimmer; R L Medcalf; T M Fink; C Mattmann; P Lichter; D E Jenne
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

10.  Isolation, purification, and properties of respiratory mucus glycoproteins.

Authors:  H Woodward; B Horsey; V P Bhavanandan; E A Davidson
Journal:  Biochemistry       Date:  1982-02-16       Impact factor: 3.162

View more
  17 in total

1.  Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum.

Authors:  Kelli L Palmer; Lindsay M Aye; Marvin Whiteley
Journal:  J Bacteriol       Date:  2007-09-14       Impact factor: 3.490

Review 2.  Mechanisms of phagocytosis and host clearance of Pseudomonas aeruginosa.

Authors:  Rustin R Lovewell; Yash R Patankar; Brent Berwin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-01-24       Impact factor: 5.464

3.  Conditions associated with the cystic fibrosis defect promote chronic Pseudomonas aeruginosa infection.

Authors:  Benjamin J Staudinger; Jocelyn Fraga Muller; Skarphéðinn Halldórsson; Blaise Boles; Angus Angermeyer; Dao Nguyen; Henry Rosen; Olafur Baldursson; Magnús Gottfreðsson; Guðmundur Hrafn Guðmundsson; Pradeep K Singh
Journal:  Am J Respir Crit Care Med       Date:  2014-04-01       Impact factor: 21.405

4.  Flagellar motility is a key determinant of the magnitude of the inflammasome response to Pseudomonas aeruginosa.

Authors:  Yash R Patankar; Rustin R Lovewell; Matthew E Poynter; Jeevan Jyot; Barbara I Kazmierczak; Brent Berwin
Journal:  Infect Immun       Date:  2013-03-25       Impact factor: 3.441

5.  Pseudomonas aeruginosa exhibits sliding motility in the absence of type IV pili and flagella.

Authors:  Thomas S Murray; Barbara I Kazmierczak
Journal:  J Bacteriol       Date:  2007-12-07       Impact factor: 3.490

Review 6.  Pseudomonas aeruginosa virulence and therapy: evolving translational strategies.

Authors:  Jeffrey L Veesenmeyer; Alan R Hauser; Thiago Lisboa; Jordi Rello
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

7.  Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia.

Authors:  Ali A El Solh; Morohunfolu E Akinnusi; Jeanine P Wiener-Kronish; Susan V Lynch; Lilibeth A Pineda; Kristie Szarpa
Journal:  Am J Respir Crit Care Med       Date:  2008-05-08       Impact factor: 21.405

Review 8.  Proteases and cystic fibrosis.

Authors:  Judith A Voynow; Bernard M Fischer; Shuo Zheng
Journal:  Int J Biochem Cell Biol       Date:  2008-03-14       Impact factor: 5.085

9.  Why is Pseudomonas aeruginosa a pathogen?

Authors:  Joanna B Goldberg
Journal:  F1000 Biol Rep       Date:  2010-04-27

Review 10.  The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung.

Authors:  Matthew S Twigg; Simon Brockbank; Philip Lowry; S Peter FitzGerald; Clifford Taggart; Sinéad Weldon
Journal:  Mediators Inflamm       Date:  2015-06-21       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.